Published recall report · See noticeUpdated · 4 months ago
ENDO USA, Inc. recall: Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
- Producer
- ENDO USA, Inc.
- Brand
- BUPRENORPHINE HYDROCHLORIDE
84132
- Dates on pack
- Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
More detail
Crystallization; identified as Buprenorphine free base
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.